Literature DB >> 18431583

[Longitudinal effects of structured patient education programs for vasculitis patients].

K Herlyn1, W L Gross, E Reinhold-Keller.   

Abstract

According to the literature it is known that structured standardized patient education represents an effective additional treatment in patients with chronic diseases. Positive effects in the reduction of disease activity and depression have been shown for rheumatoid arthritis, systemic lupus erythematodes, and diabetes mellitus. An interdisciplinary approach for providing information was developed for patients with primary systemic vasculitides (PSV) in the vasculitis center in Bad Bramstedt. The contents of the seminars were revised and condensed into five modules. To evaluate the new form of the program a documentation system was designed. Patients were trained in closed groups (n=10-15) and completed the questionnaires at baseline, 4 weeks, 6 and 12 months following participation. A total of 102 patients in 10 closed groups showed a statistically significant increase in their knowledge in the three aspects of medicine, therapy and side effects, nutrition and physiotherapy. Health-related quality of life in all dimensions increased considerably. Both self-efficacy and the patient-assessed health status improved. The standardized structured education program for vasculitis patients provides an additional treatment in the interdisciplinary care of vasculitis.

Entities:  

Mesh:

Year:  2008        PMID: 18431583     DOI: 10.1007/s00393-008-0290-9

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  8 in total

1.  [Quality standards of the German Society of Rheumatology for Rheumatologic Patient Education--preliminary report, discharged by the governing body and with consultation of the German Society of Rheumatology in September 1999].

Authors:  H E Langer; I Ehlebracht-König; S Mattussek
Journal:  Z Rheumatol       Date:  2000-08       Impact factor: 1.372

2.  If knowledge is power, why don't rheumatoid arthritis education programs show better outcomes?

Authors:  Linda C Li
Journal:  J Rheumatol       Date:  2007-08       Impact factor: 4.666

3.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

Review 4.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

5.  [A new training program--a status report: vasculitis].

Authors:  K Herlyn; J Höder; W L Gross; E Reinhold-Keller
Journal:  Z Rheumatol       Date:  2005-04       Impact factor: 1.372

6.  [Scientifically based patient education exemplified by patients with primary systemic vasculitis. The vasculitis patient education program--development, contents and initial results of evaluation].

Authors:  K Herlyn; J Höder; W L Gross; E Reinhold-Keller
Journal:  Z Rheumatol       Date:  2002-02       Impact factor: 1.372

7.  Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register.

Authors:  Eva Reinhold-Keller; Karen Herlyn; Rosemarie Wagner-Bastmeyer; Wolfgang L Gross
Journal:  Arthritis Rheum       Date:  2005-02-15

8.  Effect of a collective educational program for patients with rheumatoid arthritis: a prospective 12-month randomized controlled trial.

Authors:  Janine-Sophie Giraudet-Le Quintrec; Anne Mayoux-Benhamou; Philippe Ravaud; Karine Champion; Emmanuelle Dernis; Djamila Zerkak; Amel Ouslimani; Jean-Pierre Courpied; Michel Revel; André Kahan; Maxime Dougados
Journal:  J Rheumatol       Date:  2007-06-15       Impact factor: 4.666

  8 in total
  8 in total

Review 1.  [Current guidelines on ANCA-associated vasculitides : Common features and differences].

Authors:  B Hellmich
Journal:  Z Rheumatol       Date:  2017-03       Impact factor: 1.372

Review 2.  [S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis].

Authors:  Jan Henrik Schirmer; Peer M Aries; Kirsten de Groot; Bernhard Hellmich; Julia U Holle; Christian Kneitz; Ina Kötter; Peter Lamprecht; Ulf Müller-Ladner; Eva Reinhold-Keller; Christof Specker; Michael Zänker; Frank Moosig
Journal:  Z Rheumatol       Date:  2017-11       Impact factor: 1.372

Review 3.  [The significance of health-related quality of life in systemic vasculitides].

Authors:  K Herlyn; F Moosig; W L Gross
Journal:  Z Rheumatol       Date:  2010-05       Impact factor: 1.372

Review 4.  [Myalgia in polymyalgia rheumatica, temporal arteritis and other vasculitides].

Authors:  W A Schmidt
Journal:  Z Rheumatol       Date:  2009-08       Impact factor: 1.372

5.  The informational needs of patients with ANCA-associated vasculitis-development of an informational needs questionnaire.

Authors:  Janice Mooney; Nicola Spalding; Fiona Poland; Peter Grayson; Renee Leduc; Carol A McAlear; Rachel L Richesson; Denise Shereff; Peter A Merkel; Richard A Watts
Journal:  Rheumatology (Oxford)       Date:  2014-03-12       Impact factor: 7.580

6.  Cinematic rendering in rheumatic diseases-Photorealistic depiction of pathologies improves disease understanding for patients.

Authors:  Milena L Pachowsky; Harriet Morf; David Simon; Verena Schönau; Larissa Valor-Mendez; Johannes Knitza; Filippo Fagni; Klaus Engel; Michael Uder; Axel Hueber; Christian Schmidkonz; Georg Schett; Arnd Kleyer
Journal:  Front Med (Lausanne)       Date:  2022-08-03

7.  Exploring the educational needs of patients with systemic vasculitis using the educational needs assessment tool.

Authors:  Sara Brolin; Elisabet Welin; Björn Lövström; Annette Bruchfeld; Iva Gunnarsson; Susanne Pettersson
Journal:  Rheumatol Adv Pract       Date:  2022-08-11

8.  Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis.

Authors:  Sara Monti; Ana F Águeda; Raashid Ahmed Luqmani; Frank Buttgereit; Maria Cid; Christian Dejaco; Alfred Mahr; Cristina Ponte; Carlo Salvarani; Wolfgang Schmidt; Bernhard Hellmich
Journal:  RMD Open       Date:  2019-09-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.